More News

02 Apr 2018 XBiotech In-licenses Anti-NY-ESO-1 Antibody Targeting Advanced Cancer
29 Mar 2018 Indivior Enters Into an Exclusive Global License Agreement for C4X Discovery's Orexin-1 (OX1) Antagonist Program
28 Mar 2018 Actinium Pharmaceuticals Announces Collaborative Research Partnership with Astellas Leveraging Actinium’s AWE Platform Technology
28 Mar 2018 bluebird bio and Celgene Corporation Enter into Agreement to Co-Develop and Co-Promote Anti-BCMA CAR T Cell Therapy bb2121 in the United States
28 Mar 2018 Abide and Celgene Enter Worldwide License Agreement for ABX-1772
28 Mar 2018 Eisai and Nichi-Iko Pharmaceutical enter into strategic alliance agreement
26 Mar 2018 Shire and NanoMedSyn Enter Into Research Agreement for Potential Lysosomal Storage Disorder Treatment
22 Mar 2018 CBT Pharmaceuticals to Grow Immuno-Oncology Pipeline by License Agreement of CrownBio CTLA-4 Antibody
22 Mar 2018 Innate Biologics, LLC Enters Into Collaboration Agreement With The Wistar Institute to Develop Anti-Inflammatory Protein Platform
22 Mar 2018 Regeneron and Alnylam Pharmaceuticals Announce Collaboration to Discover New Treatments for Nonalcoholic Steatohepatitis (NASH)
22 Mar 2018 Helix BioPharma Corp. Signs Collaboration Agreement With ProMab Biotechnologies to Co-Develop CAR-T for Hematological Malignancies
21 Mar 2018 Prothena Announces Global Neuroscience Research & Development Collaboration with Celgene for Novel Therapies for Patients with Neurodegenerative Diseases
21 Mar 2018 Inovio Closes License and Collaboration Agreement with ApolloBio To Develop and Commercialize VGX-3100 in Greater China
20 Mar 2018 Novartis teams up with Harvard to develop next generation biomaterial systems to deliver immunotherapies
19 Mar 2018 Mundipharma expands biosimilar portfolio with exclusive partnership deal across seven European countries for trastuzumab biosimilar, Herzuma®
16 Mar 2018 Bavarian Nordic Announces Partnership with U.S. Department of Defense to Combat Equine Encephalitis Virus
16 Mar 2018 Lundbeck to acquire Prexton Therapeutics in a deal valued at up to €905 million
16 Mar 2018 Boehringer Ingelheim and Vanderbilt University Expand Partnership to Develop Novel Treatment Approaches for Cancer
15 Mar 2018 Ionis and Akcea Partner to Commercialize Inotersen for hATTR
15 Mar 2018 Crinetics Pharmaceuticals Completes $63.5 Million Series B Financing
14 Mar 2018 Escalier Biosciences Raises $19 Million to Develop its Topical and Systemic RORγt Therapies for Psoriasis and other Autoimmune Diseases
14 Mar 2018 AveXis Enters into Licensing Agreement with Genethon
12 Mar 2018 Biogen to Acquire from Pfizer First-in-Class Phase 2b Ready Asset for Cognitive Impairment Associated with Schizophrenia
08 Mar 2018 Zydus partners with Medicure to launch its NDA Product, ZYPITAMAG (pitavastatin) in the U.S.
07 Mar 2018 MD Anderson and Berkeley Lights Launch Optera Therapeutics to Accelerate Development of Cell Therapies for Cancer

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up